DN
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Prevention and management of febrile neutropenia in acute myeloid leukaemia and higher risk myelodysplastic syndrome : An international survey of current practice | British journal of haematology | 2026 | 2 | 30 | |||
| Incidence and Risk Factors for Infection in Heart Transplant Recipients on Posttransplant Extracorporeal Membrane Oxygenation (ECMO) | Transplantation direct | 2025 | 16 | 39 | |||
| Comparing variable and feature selection strategies for prediction - protocol of a simulation study in low-dimensional transplantation data | PloS one | 2025 | 16 | 121 | |||
| Old Pathogens-New Patient Types : Infections in a CAR T-Cell Recipient. Could It Get Any More Complicated ? | Transplant infectious disease | 2025 | 8 | 48 | |||
| The Importance of MRI in the Early Diagnosis of Acute Invasive Fungal Rhinosinusitis | Diagnostics | 2025 | 154 | 177 | |||
| Defining bloodstream and central venous catheter-related infections in patients following haematopoietic cell transplantation : position paper of the European Blood and Marrow Transplantation Society Infectious Diseases Working Party and Practice Harmonization and Guidelines Committee | Clinical microbiology and infection | 2025 | 2 | 0 | |||
| Blood virome after allogeneic hematopoietic stem cell transplantation | Open forum infectious diseases | 2025 | 61 | 110 | |||
| Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation : recommendations from the 10th European Conference on Infections in Leukaemia | The Lancet Infectious Diseases | 2025 | 9 | 0 | |||
| Isolation measures during the COVID-19 pandemic in transplant units may decrease respiratory infection rates and improve non-relapse mortality | Bone marrow transplantation | 2025 | 6 | 0 | |||
| Pneumonia definition in allogeneic hematopoietic cell transplant recipients : Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee | Current research in translational medicine | 2025 | 10 | 26 | |||
| Invasive Candida infections in solid organ transplant recipients between 2008 and 2020 | American Journal of Transplantation | 2025 | 21 | 81 | |||
| Breakthrough Invasive Mould Infections Under Posaconazole Prophylaxis in Patients With Haematologic Malignancies : A Case-Control Study | Mycoses | 2025 | 7 | 64 | |||
| Management of Clostridioides difficile infection in patients with haematological malignancies and after cellular therapy : guidelines from 10th European Conference on Infections in Leukaemia (ECIL - 10) | EClinicalMedicine | 2025 | 5 | 71 | |||
| Population pharmacokinetic analysis of letermovir in adult hematopoietic cell transplant recipients | Antimicrobial agents and chemotherapy | 2025 | 9 | 28 | |||
| Surgical site infections, risk factors, and outcomes after liver transplant | JAMA network open | 2025 | 74 | 208 | |||
| Epidemiology of resistant bacterial infections in patients with hematological malignancies or undergoing hematopoietic cell transplantation in Europe : A systematic review by the European Conference on Infections in Leukemia (ECIL) | The Journal of infection | 2025 | 7 | 56 | |||
| Management of Invasive Pulmonary Aspergillosis in Intensive Care Units : Guidelines From the Fungal Infection Network of Switzerland (FUNGINOS) | Mycoses | 2025 | 10 | 311 | |||
| Epidemiology of hospital-acquired bloodstream infections in haemato-oncology patients in Geneva, Switzerland | Infection | 2025 | 38 | 190 | |||
| Antifungal treatment duration in hematology patients with invasive mold infections : a real-life update | Open forum infectious diseases | 2024 | 90 | 99 | |||
| Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients : An Update | Viruses | 2024 | 6 | 77 | |||
| Effectiveness, Safety, and Patterns of Real-World Isavuconazole Use in Europe (2015–2019) | Infectious diseases and therapy | 2024 | 9 | 66 | |||
| Reexploring cytomegalovirus serology in allogeneic hematopoietic cell transplantation | Current opinion in infectious diseases | 2024 | 107 | 128 | |||
| Isavuconazole for the Treatment of Fungal Infections : A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS) | Open forum infectious diseases | 2024 | 84 | 199 | |||
| An Update on Breakthrough Invasive Mold Infections | Mycopathologia | 2024 | 7 | 61 | |||
| Current practice of screening and antimicrobial prophylaxis to prevent Gram-negative bacterial infection in high-risk haematology patients : results from a pan-European survey | Therapeutic advances in infectious disease | 2024 | 6 | 25 | |||
| Clinicopathologic conference : Bloodstream infection in an allogeneic hamatopoietic cell transplant : Thinking beyond the usual | Transplant infectious disease | 2024 | 35 | 72 | |||
| Do infectious diseases after kidney retransplantation differ from those after first kidney transplantation ? | Open forum infectious diseases | 2024 | 114 | 105 | |||
| Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients | Transplant international | 2024 | 112 | 128 | |||
| BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort Study | American journal of transplantation | 2024 | 49 | 95 | |||
| Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients : A multicenter cohort, 2015-2020 | American journal of transplantation | 2024 | 30 | 31 | |||
| Surgical site infections after kidney transplantation are independently associated with graft loss | American journal of transplantation | 2024 | 59 | 200 | |||
| Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species | Frontiers in medicine | 2024 | 87 | 34 | |||
| Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis | Transplant infectious disease | 2024 | 64 | 149 | |||
| Bacterial infections in solid organ transplant recipients | Current opinion in organ transplantation | 2024 | 28 | 1 | |||
| Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter study | Bone marrow transplantation | 2024 | 80 | 82 | |||
| How I treat : Coronavirus disease 2019 in leukemic patients and hematopoietic cell transplant recipients | Transplant infectious disease | 2024 | 8 | 60 | |||
| Pitfalls in definitions on respiratory viruses and particularities of Adenovirus infection in hematopoietic cell transplantation patients : Recommendations from the EBMT practice harmonization and guidelines committee | Current research in translational medicine | 2024 | 53 | 111 | |||
| Invasive aspergillosis in liver transplant recipients in the current era | American journal of transplantation | 2024 | 22 | 0 | |||
| Routine infectious disease consultation prior to an allogeneic hematopoietic cell transplant | Open forum infectious diseases | 2023 | 84 | 119 | |||
| Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities : A Multi-Center Retrospective Study | Journal of Fungi | 2023 | 94 | 168 | |||
| 'Which trial do we need ? Culture of preservation fluid in abdominal organ transplant recipients' Author's reply | Clinical microbiology and infection | 2023 | 7 | 42 | |||
| Vaccine-preventable infections among solid organ transplant recipients in Switzerland | JAMA network open | 2023 | 135 | 157 | |||
| Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipients | Clinical infectious diseases | 2023 | 103 | 168 | |||
| Antifungal prophylaxis and pre-emptive therapy : when and how ? | Molecular aspects of medicine | 2023 | 83 | 55 | |||
| Which trial do we need ? Culture of preservation fluid in abdominal organ transplant recipients | Clinical microbiology and infection | 2023 | 7 | 24 | |||
| Duration of antifungal treatment in mold infection : when is enough ? | Current opinion in infectious diseases | 2023 | 90 | 55 | |||
| The present and future of blood virome in allogeneic hematopoietic cell transplant recipients | Current opinion in infectious diseases | 2023 | 95 | 146 | |||
| Bloodstream infections in allogeneic haematopoietic cell recipients from the swiss transplant cohort study: trends of causative pathogens and resistance rates | Bone marrow transplantation | 2023 | 152 | 95 | |||
| American Society for Transplantation and Cellular Therapy Series, #6 : Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients | Transplantation and cellular therapy | 2023 | 81 | 132 | |||
| CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients | Open forum infectious diseases | 2023 | 139 | 103 | |||
| Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients : The STOP-FLU trial | Clinical infectious diseases | 2023 | 106 | 180 | |||
| Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial | Clinical infectious diseases | 2023 | 148 | 259 | |||
| Invasive Aspergillosis and the Impact of Azole-resistance | Current fungal infection reports | 2023 | 70 | 192 | |||
| Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma | Viruses | 2023 | 156 | 148 | |||
| Bacteremia During the First Year After Solid Organ Transplantation : An Epidemiological Update | Open forum infectious diseases | 2023 | 127 | 118 | |||
| Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients | Antimicrobial agents and chemotherapy | 2023 | 105 | 358 | |||
| Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant | Open forum infectious diseases | 2023 | 68 | 103 | |||
| Nouveautés dans la prise en charge de l’infection à cytomégalovirus chez les patients transplantés | Revue médicale suisse | 2023 | 95 | 80 | |||
| Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress? | Open forum infectious diseases | 2022 | 271 | 238 | |||
| Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study | The Journal of infection | 2022 | 256 | 245 | |||
| Friends and foes : “The quarrels of friends are the opportunities of foes” | Current opinion in infectious diseases | 2022 | 8 | 0 | |||
| Atypical pulmonary phaeohyphomycosis due to Aureobasidium spp. - case report and brief literature review | Swiss medical weekly | 2022 | 184 | 86 | |||
| Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals | Open forum infectious diseases | 2022 | 235 | 183 | |||
| Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients | Antimicrobial agents and chemotherapy | 2022 | 105 | 290 | |||
| Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections | Mycoses | 2022 | 305 | 197 | |||
| Impact of different urinary tract infection phenotypes within the first year post-transplant on renal allograft outcomes | American journal of transplantation | 2022 | 190 | 129 | |||
| Letermovir for cytomegalovirus primary prophylaxis in a multiple abdominal/small bowel transplant recipient | Clinical transplantation | 2022 | 257 | 0 | |||
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | 2022 | 244 | 139 | |||
| T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | 2022 | 263 | 130 | |||
| When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients? | Mycoses | 2022 | 101 | 82 | |||
| Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study | The Journal of hospital infection | 2022 | 253 | 134 | |||
| Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients | American journal of transplantation | 2022 | 212 | 131 | |||
| Screening for Parasitic Infection and Tuberculosis in Immunosuppressed and Pre-Immunosuppressed Patients: An Observational Study | Tropical medicine and infectious disease | 2021 | 245 | 229 | |||
| COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it? | Clinical microbiology and infection | 2021 | 236 | 155 | |||
| Progress and current challenges in the management of invasive fungal infections in hematologic malignancy patients and allogeneic hematopoietic cell transplant recipients | 2021 | 342 | 510 | ||||
| Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study | Vaccines | 2021 | 206 | 287 | |||
| Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study | American journal of transplantation | 2021 | 280 | 189 | |||
| Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high-risk hematopoietic cell transplant recipients | Immunity, inflammation and disease | 2021 | 373 | 198 | |||
| Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018 | Antimicrobial resistance and infection control | 2021 | 385 | 150 | |||
| Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study | American journal of transplantation | 2021 | 153 | 137 | |||
| Clinical considerations of isavuconazole administration in high-risk hematological patients: a single-center 5-year experience | Mycopathologia | 2021 | 244 | 250 | |||
| Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients | Medical mycology | 2021 | 361 | 1 | |||
| Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response | BMC infectious diseases | 2021 | 157 | 306 | |||
| Differences between infectious disease events in first liver transplant versus retransplantation in the Swiss Transplant Cohort Study | Liver transplantation | 2021 | 143 | 0 | |||
| Editorial: Transplant infectious disease landscape in the COVID19-Era | Current opinion in infectious diseases | 2021 | 195 | 0 | |||
| The EHA research roadmap: infections in hematology | HemaSphere | 2021 | 231 | 231 | |||
| Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir | Antimicrobial agents and chemotherapy | 2021 | 250 | 430 | |||
| Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey | Open forum infectious diseases | 2021 | 105 | 125 | |||
| Real-life considerations on antifungal treatment combinations for the management of invasive mold infections after allogeneic cell transplantation | Journal of Fungi | 2021 | 189 | 149 | |||
| Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study | The journal of antimicrobial chemotherapy | 2021 | 213 | 0 | |||
| Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients | Medical mycology | 2021 | 167 | 0 | |||
| Invasive aspergillosis due to Aspergillus section Usti: a multicenter retrospective study | Clinical Infectious Diseases | 2020 | 253 | 709 | |||
| Risk factors for candidemia: a prospective matched case-control study | Critical Care | 2020 | 385 | 206 | |||
| Response to "Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study" | Blood advances | 2020 | 205 | 67 | |||
| Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland | Infection | 2020 | 248 | 227 | |||
| First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study | American Journal of Transplantation | 2020 | 295 | 151 | |||
| Intracellular Pathogen in the Cerebrospinal Fluid of an Allogeneic Hematopoietic Cell Transplant Recipient With Graft-Versus-Host Disease and Brain Lesions | Clinical infectious diseases | 2020 | 274 | 0 | |||
| Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigm | Medical Mycology | 2020 | 223 | 329 | |||
| Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipients | Open Forum Infectious Diseases | 2020 | 464 | 148 | |||
| First case of Cryptococcus gattii multilobar pneumonia in Switzerland and associated challenges | Swiss Medical Weekly | 2020 | 386 | 178 | |||
| Combination treatment with letermovir and ganciclovir for maintenance therapy of multidrug-resistant CMV infection in a liver transplant recipient | Transplantation | 2020 | 348 | 1 | |||
| Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort study | Transplant Infectious Disease | 2020 | 406 | 2 | |||
| Prophylaxie antimicrobienne et approches thérapeutiques empiriques et préemptives pour la prévention des infections chez les receveurs de greffe allogénique de cellules hématopoïétiques | 2020 | 567 | 251 | ||||
| Infectiologie sur mesure - 1. Immunogénétique des maladies infectieuses : premiers pas | Revue médicale suisse | 2019 | 299 | 4 | |||
| National point prevalence survey on healthcare-associated infections in acute care hospitals, Switzerland, 2017 | Euro Surveillance | 2019 | 377 | 267 | |||
| Antimicrobial prophylaxis and preemptive approaches for the prevention of infections in the stem cell transplant recipient, with analogies to the hematologic malignancy patient | Infectious disease clinics of North America | 2019 | 178 | 498 | |||
| Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study | Transplant Infectious Disease | 2018 | 592 | 0 | |||
| Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy | Haematologica | 2018 | 252 | 213 | |||
| Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS) | Clinical Microbiology and Infection | 2018 | 328 | 230 | |||
| Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients | Transplant Infectious Disease | 2018 | 335 | 199 | |||
| Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study | Transplant Infectious Disease | 2018 | 471 | 0 | |||
| Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort | Transplant Infectious Disease | 2018 | 384 | 1 | |||
| First case of Candida auris in Switzerland: discussion about preventive strategies | Swiss Medical Weekly | 2018 | 507 | 297 |
